Relation between diuretic agents and aldosterone in cardiac and cirrhotic patients with sodium retention.
作者信息
THOMAS J P, BARTTER F C
出版信息
Br Med J. 1961 Apr 22;1(5233):1134-9. doi: 10.1136/bmj.1.5233.1134.
Abstract
摘要
相似文献
1
Relation between diuretic agents and aldosterone in cardiac and cirrhotic patients with sodium retention.
Br Med J. 1961 Apr 22;1(5233):1134-9. doi: 10.1136/bmj.1.5233.1134.
2
[Spirolactones. Their use in the treatment of cardiac and cirrhotic edemas (apropos of 6 case reports)].
Sem Hop. 1960 Dec 4;36:3083-97.
3
[Spirolactone. Its use in the treatment of cardiac and cirrhotic edema. Apropos of 6 case reports].
Sem Hop Ther Paris. 1961 Mar;37:197-211.
4
A comparison of the properties of chlorothiazide, spironolactone and a combination of both as diuretic agents.
N Engl J Med. 1961 Aug 24;265:358-62. doi: 10.1056/NEJM196108242650802.
5
[Aldactone (antialdosterone SC-9420) in the treatment of the edema of cardiac and cirrhoticpatients. Bioclinical study. I].
Ann Biol Clin (Paris). 1962 May-Jun;20:497-524.
6
[Aldactone (aldosterone antagonist SC-9, 420) in the treatment of the edemas of heart patients and cirrhotic patients. Bioclinical study].
J Sci Med Lille. 1962 May;80:225-35.
7
[Aldostegone-antagonistic steroids as diuretics. Spironolactone in the treatment of hepatic and cardiac edemas].
Dtsch Med Wochenschr. 1961 Dec 8;86:2395-402. doi: 10.1055/s-0028-1113105.
8
[Urine aldosterone in cardiac patients resistant to mercurial diuretics].
Munch Med Wochenschr. 1960 Apr 22;102:827-9.
9
The use of L-lysine monomydrochloride in combination with mercurial diuretics in the treatment of refractory fluid retention.
Circulation. 1960 Mar;21:332-6. doi: 10.1161/01.cir.21.3.332.
引用本文的文献
1
IMPAIRED ALDOSTERONE PRODUCTION IN "SALT-LOSING" CONGENITAL ADRENAL HYPERPLASIA.
J Clin Invest. 1965 Jun;44(6):957-65. doi: 10.1172/JCI105213.
2
ON THE CONCENTRATING DEFECT IN CIRRHOSIS OF THE LIVER.
J Clin Invest. 1964 Feb;43(2):258-66. doi: 10.1172/JCI104910.
3
The urinary sodium: potassium ratio and response to diuretics in resistant oedema.
Postgrad Med J. 1977 Mar;53(617):117-21. doi: 10.1136/pgmj.53.617.117.
本文引用的文献
1
THE EFFECTS OF INTRAVENOUS INJECTION OF CONCENTRATED HUMAN SERUM ALBUMIN UPON BLOOD PLASMA, ASCITES AND RENAL FUNCTIONS IN THREE PATIENTS WITH CIRRHOSIS OF THE LIVER.
J Clin Invest. 1948 Jan;27(1):135-44. doi: 10.1172/JCI101916.
2
EDEMA AND DECREASED RENAL BLOOD FLOW IN PATIENTS WITH CHRONIC CONGESTIVE HEART FAILURE: EVIDENCE OF "FORWARD FAILURE" AS THE PRIMARY CAUSE OF EDEMA.
J Clin Invest. 1946 May;25(3):389-400. doi: 10.1172/JCI101720.
3
CARDIAC OUTPUT, BLOOD AND INTERSTITIAL FLUID VOLUMES, TOTAL CIRCULATING SERUM PROTEIN, AND KIDNEY FUNCTION DURING CARDIAC FAILURE AND AFTER IMPROVEMENT.
J Clin Invest. 1942 Mar;21(2):229-40. doi: 10.1172/JCI101294.
4
Salt retention in cirrhosis of the liver.
J Clin Invest. 1950 Aug;29(8):973-81. doi: 10.1172/JCI102344.
5
Renal hemodynamics in heart disease.
Am Heart J. 1950 Feb;39(2):188-204. doi: 10.1016/0002-8703(50)90216-x.
6
The relationship of plasma pH and anion pattern to mercurial diuresis.
J Clin Invest. 1952 Feb;31(2):171-9. doi: 10.1172/JCI102587.
7
Relationship between acidification of the urine and potassium metabolism; effect of carbonic anhydrase inhibition on potassium excretion.
Am J Med. 1951 Sep;11(3):274-82. doi: 10.1016/0002-9343(51)90165-9.
8
Resistant ascites treated by combined diuretic therapy (spironolactone, mannitol, and chlorothiazide).
Lancet. 1960 Mar 19;1(7125):609-13. doi: 10.1016/s0140-6736(60)90500-6.
9
An explanation for and experimental correction of the abnormal water diuresis in cirrhosis.
J Clin Invest. 1960 Feb;39(2):248-61. doi: 10.1172/JCI104035.
10
Double isotope derivative assay of aldosterone in biological extracts.
J Biol Chem. 1960 Jun;235:1639-48.
Zotero 插件